WallStreetZenWallStreetZen

NASDAQ: AGIO
Agios Pharmaceuticals Inc Stock Ownership - Who owns Agios Pharmaceuticals?

Insider buying vs selling

Have Agios Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Kaye I. FostercheekDirector2024-03-071,285$31.62
$40.63kSell
Kaye I. FostercheekDirector2024-03-064,415$31.99
$141.24kSell
Brian GoffChief Executive Officer2024-03-054,156$32.57
$135.36kSell
Cecilia JonesChief Financial Officer2024-03-05672$32.57
$21.89kSell
James William BurnsChief Legal Officer2024-03-051,349$32.57
$43.94kSell
James William BurnsChief Legal Officer2024-03-051,293$32.57
$42.11kSell
Theodore James Washburn Jr.Principal Accounting Officer2024-03-05919$32.57
$29.93kSell
Kaye I. FostercheekDirector2024-03-05300$32.21
$9.66kSell
Theodore James Washburn Jr.Principal Accounting Officer2024-03-051,913$31.75
$60.74kSell
Sarah GheuensChief Medical Officer2024-03-051,349$32.57
$43.94kSell

1 of 6

AGIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AGIO insiders and whales buy or sell their stock.

AGIO Shareholders

What type of owners hold Agios Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Celgene European Investment Co LLC10.44%5,867,279$170.86MInsider
Vanguard Group Inc9.84%5,527,438$160.96MInstitution
Blackrock Inc8.83%4,962,237$144.50MInstitution
Farallon Capital Management LLC7.42%4,167,602$121.36MInstitution
Bellevue Group Ag7.14%4,011,000$116.80MInstitution
Robert Nelsen7.06%3,969,968$115.61MInsider
Armistice Capital LLC6.27%3,524,000$102.62MInstitution
Arch Venture Fund Vii LP5.50%3,088,590$89.94MInsider
State Street Corp4.67%2,625,685$76.46MInstitution
Dimensional Fund Advisors LP4.62%2,596,764$75.62MInstitution

1 of 3

AGIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AGIO75.10%24.90%Net SellingNet Selling
INBX72.56%27.44%Net Buying
KURA90.77%9.23%Net BuyingNet Selling
VCYT64.44%35.56%Net SellingNet Selling
PTGX79.91%20.09%Net SellingNet Selling

Agios Pharmaceuticals Stock Ownership FAQ

Who owns Agios Pharmaceuticals?

Agios Pharmaceuticals (NASDAQ: AGIO) is owned by 102.81% institutional shareholders, 34.10% Agios Pharmaceuticals insiders, and 0.00% retail investors. Celgene European Investment Co LLC is the largest individual Agios Pharmaceuticals shareholder, owning 5.87M shares representing 10.44% of the company. Celgene European Investment Co LLC's Agios Pharmaceuticals shares are currently valued at $171.56M.

If you're new to stock investing, here's how to buy Agios Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.